A tailored dose of tenofovir could reduce its impact on bone mass in HIV Type 1-infected children and adolescents: a report from 5 years of clinical experience

MeSH terms

• Adenine / administration & dosage
• Adenine / adverse effects
• Adenine / analogs & derivatives*
• Adolescent
• Anti-HIV Agents / administration & dosage*
• Anti-HIV Agents / adverse effects*
• Antiretroviral Therapy, Highly Active / adverse effects
• Antiretroviral Therapy, Highly Active / methods
• Bone and Bones / physiology*
• Calcification, Physiologic / drug effects*
• Child
• Child, Preschool
• Female
• HIV Infections / drug therapy*
• HIV Infections / virology
• HIV-1 / isolation & purification
• Humans
• Male
• Organophosphonates / administration & dosage*
• Organophosphonates / adverse effects*
• Tenofovir